Bacterial expression and purification of functional recombinant SARS-CoV-2 spike receptor binding domain
Abstract The COVID-19 pandemic caused by SARS-CoV-2 has applied significant pressure on overtaxed healthcare around the world, underscoring the urgent need for rapid diagnosis and treatment. We have developed a bacterial strategy for the expression and purification of the SARS-CoV-2 spike protein receptor binding domain using the CyDisCo system to create and maintain the correct disulfide bonds for protein integrity and functionality. We show that it is possible to quickly and inexpensively produce functional, active antigen in bacteria capable of recognizing and binding to the ACE2 (angiotensin-converting enzyme) receptor as well as antibodies in COVID-19 patient sera..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
bioRxiv.org - (2021) vom: 05. Feb. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Prahlad, Janani [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| doi: |
10.1101/2021.02.03.429601 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI019877099 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI019877099 | ||
| 003 | DE-627 | ||
| 005 | 20230429083803.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210205s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2021.02.03.429601 |2 doi | |
| 035 | |a (DE-627)XBI019877099 | ||
| 035 | |a (DE-599)biorXiv10.1101/2021.02.03.429601 | ||
| 035 | |a (biorXiv)10.1101/2021.02.03.429601 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 570 |q DE-84 | |
| 100 | 1 | |a Prahlad, Janani |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Bacterial expression and purification of functional recombinant SARS-CoV-2 spike receptor binding domain |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract The COVID-19 pandemic caused by SARS-CoV-2 has applied significant pressure on overtaxed healthcare around the world, underscoring the urgent need for rapid diagnosis and treatment. We have developed a bacterial strategy for the expression and purification of the SARS-CoV-2 spike protein receptor binding domain using the CyDisCo system to create and maintain the correct disulfide bonds for protein integrity and functionality. We show that it is possible to quickly and inexpensively produce functional, active antigen in bacteria capable of recognizing and binding to the ACE2 (angiotensin-converting enzyme) receptor as well as antibodies in COVID-19 patient sera. | ||
| 700 | 1 | |a Struble, Lucas R. |e verfasserin |4 aut | |
| 700 | 1 | |a Lutz, William E. |e verfasserin |4 aut | |
| 700 | 1 | |a Wallin, Savanna A. |e verfasserin |4 aut | |
| 700 | 1 | |a Khurana, Surender |e verfasserin |4 aut | |
| 700 | 1 | |a Schnaubelt, Andy |e verfasserin |4 aut | |
| 700 | 1 | |a Broadhurst, Mara J. |e verfasserin |4 aut | |
| 700 | 1 | |a Bayles, Kenneth W. |e verfasserin |4 aut | |
| 700 | 1 | |a Borgstahl, Gloria E. O. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2021) vom: 05. Feb. |
| 773 | 1 | 8 | |g year:2021 |g day:05 |g month:02 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2021.02.03.429601 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2021 |b 05 |c 02 | ||
| 953 | |2 045F |a 570 | ||